Bottom line
Is HDEF a good fund? The bottom line
HDEF is an index dividend & equity income ETF from DWS (Xtrackers).
Annual fees run 0.09% — about $9 a year on every $10,000 invested, cheaper than 95% of dividend & equity income funds we track.
With $2.3 billion in net assets and 124 holdings, its largest position is Roche Holding Ag (5.0%) and the top 10 make up 41.1% of the portfolio.
What stands out
- Low cost: cheaper than 95% of dividend & equity income peers
Updated Nov 19, 2026
What HDEF invests in
The fund seeks investment results that correspond generally to the performance, before fees and expenses, of the MSCI EAFE High Dividend Yield Index.
The fund, using a passive or indexing investment approach, seeks investment results that correspond generally to the performance, before fees and expenses, of the MSCI EAFE High Dividend Yield Index (the Underlying Index), which is designed to track developed market performance. The fund uses a full replication indexing strategy to seek to track the Underlying Index. As such, the fund invests directly in the component securities of the Underlying Index in substantially the same weightings in which they are represented in the Underlying Index. If it is not possible for the fund to acquire component securities due to limited availability or regulatory restrictions, the fund may use a representative sampling indexing strategy to seek to track the Underlying Index instead of a full replication indexing strategy. Representative sampling is an indexing strategy that involves investing in a…
From the fund's prospectus (filed Sep 25, 2026).
HDEF performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HDEF | — | — | — |
| Dividend & Equity Income median | +14.6% | +10.1% | +9.2% |
Source: Fund prospectus, as of
What HDEF costs
On a $10,000 investment, HDEF's 0.09% expense ratio costs about $9 a year. The prospectus estimates $115 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.
HDEF top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Roche Holding Ag ROP | 5.02% |
| 2 | Nestle' Sa/ag NESN | 4.99% |
| 3 | Novartis Ag NOVN | 4.98% |
| 4 | Shell Plc SHEL | 4.75% |
| 5 | Totalenergies Se TTE | 4.21% |
| 6 | Allianz Se ALV | 4.14% |
| 7 | Novo Nordisk A/s NOVOB | 3.59% |
| 8 | Iberdrola Sa IBE | 3.37% |
| 9 | British American Tobacco Plc BATS | 3.04% |
| 10 | Unilever Plc ULVR | 3.02% |
Source: SEC Form N-PORT, period ended May 29, 2026
The top 10 make up 41.1% of the fund. See all top 25 holdings and asset mix →